101 related articles for article (PubMed ID: 2815647)
41. Sucralfate versus placebo treatment in duodenal and prepyloric ulcer: a clinical endoscopic, double-blind controlled investigation.
Elsborg L; Boysen K; Bruusgaard A; Reinicke V
Hepatogastroenterology; 1984 Dec; 31(6):269-71. PubMed ID: 6549171
[TBL] [Abstract][Full Text] [Related]
42. Cimetidine vs placebo: complete gastric ulcer pain relief. Six week controlled double blind study without any antacid therapy.
Collen MJ; Stubrin SE; Hánan MR; Maher JA; Rent M
Acta Gastroenterol Latinoam; 1980; 10(4):291-5. PubMed ID: 7023166
[TBL] [Abstract][Full Text] [Related]
43. [The efficacy in using an extremely high-frequency electromagnetic field in the combined treatment of chronic bronchitis patients].
Danilenko SR
Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (6):16-8. PubMed ID: 9484023
[TBL] [Abstract][Full Text] [Related]
44. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
[TBL] [Abstract][Full Text] [Related]
45. [Combined therapy of duodenal ulcer associated with Helicobacter pylori with electromagnetic decimeter waves and colloidal bismuth subcitrate].
Filimonov RM; Korolev IuN; Kochineva ER
Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (6):19-22. PubMed ID: 8154113
[No Abstract] [Full Text] [Related]
46. [Is there a hepatogenic ulcer? Prospective study of the incidence of peptic ulcer in portal hypertension].
Fleig WE; Stange EF; Winkler K
Z Gastroenterol; 1987 Aug; 25 Suppl 3():47-51. PubMed ID: 3660899
[TBL] [Abstract][Full Text] [Related]
47. [Eradication of Helicobacter pylori in peptic ulcer patients].
Buzás GM; Székely E
Orv Hetil; 1999 Jan; 140(3):121-4. PubMed ID: 9990816
[TBL] [Abstract][Full Text] [Related]
48. [Laparoscopic treatment of perforated peptic ulcer].
Acevedo C; Suc B; Fourtanier G
Ann Chir; 1999; 53(1):19-22. PubMed ID: 10083664
[TBL] [Abstract][Full Text] [Related]
49. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S;
Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899
[TBL] [Abstract][Full Text] [Related]
50. [The quantitative evaluation of indications for surgical treatment of acid-peptic ulcer and its clinical usefullness (author's transl)].
Oleksy J; Herman RM; Popiela T; Legutko J
Przegl Lek; 1980; 37(6):523-7. PubMed ID: 7422928
[No Abstract] [Full Text] [Related]
51. Accurate prediction of duodenal-ulcer healing rate by discriminant analysis.
Lam SK; Koo J
Gastroenterology; 1983 Aug; 85(2):403-12. PubMed ID: 6345257
[TBL] [Abstract][Full Text] [Related]
52. A comparison of alprazolam, gefarnate and their combination in treatment of peptic ulcer patients--an application of life table analysis.
Ogawa N; Namiki M; Kusunoki T; Fujii S
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):109-11. PubMed ID: 2859256
[TBL] [Abstract][Full Text] [Related]
53. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
[TBL] [Abstract][Full Text] [Related]
54. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
Hsu CC; Lu SN; Changchien CS
Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
[TBL] [Abstract][Full Text] [Related]
55. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
[TBL] [Abstract][Full Text] [Related]
56. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
57. Coronary heart disease after radiotherapy for peptic ulcer disease.
Carr ZA; Land CE; Kleinerman RA; Weinstock RW; Stovall M; Griem ML; Mabuchi K
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):842-50. PubMed ID: 15708264
[TBL] [Abstract][Full Text] [Related]
58. [Yellow-light laser therapy of peptic ulcer].
Matiushichev VB; Soldatov AI; Titov VV
Sov Med; 1989; (5):86-9. PubMed ID: 2781386
[No Abstract] [Full Text] [Related]
59. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
60. [The potentials for using low-intensity millimeter waves in the combined sanatorium-health resort treatment of peptic ulcer patients (experimental and clinical research)].
Serebrina LA; Leshchinskiĭ AF; Zolotareva TA; Korobov SA; Okat'eva NA; Lutovskaia MA
Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (2):45-8. PubMed ID: 2385943
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
